Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 303

1.

The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer.

Tamae D, Mostaghel E, Montgomery B, Nelson PS, Balk SP, Kantoff PW, Taplin M, Penning TM.

Chem Biol Interact. 2014 Dec 13. pii: S0009-2797(14)00390-1. doi: 10.1016/j.cbi.2014.12.012. [Epub ahead of print]

PMID:
25514466
[PubMed - as supplied by publisher]
2.

Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study.

Taplin ME, Montgomery B, Logothetis CJ, Bubley GJ, Richie JP, Dalkin BL, Sanda MG, Davis JW, Loda M, True LD, Troncoso P, Ye H, Lis RT, Marck BT, Matsumoto AM, Balk SP, Mostaghel EA, Penning TM, Nelson PS, Xie W, Jiang Z, Haqq CM, Tamae D, Tran N, Peng W, Kheoh T, Molina A, Kantoff PW.

J Clin Oncol. 2014 Nov 20;32(33):3705-15. doi: 10.1200/JCO.2013.53.4578. Epub 2014 Oct 13.

PMID:
25311217
[PubMed - in process]
3.

A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-T.

McNeel DG, Gardner TA, Higano CS, Kantoff PW, Small EJ, Wener MH, Sims RB, DeVries T, Sheikh NA, Dreicer R.

Cancer Immunol Res. 2014 Oct;2(10):988-99. doi: 10.1158/2326-6066.CIR-14-0073. Epub 2014 Sep 4.

PMID:
25189164
[PubMed - in process]
4.

Contemporary Nationwide Patterns of Self-reported Prostate-Specific Antigen Screening.

Sammon JD, Pucheril D, Diaz M, Kibel AS, Kantoff PW, Menon M, Trinh QD.

JAMA Intern Med. 2014 Nov 1;174(11):1839-41. doi: 10.1001/jamainternmed.2014.4117. No abstract available.

PMID:
25179266
[PubMed - in process]
5.

Prospective enterprise-level molecular genotyping of a cohort of cancer patients.

MacConaill LE, Garcia E, Shivdasani P, Ducar M, Adusumilli R, Breneiser M, Byrne M, Chung L, Conneely J, Crosby L, Garraway LA, Gong X, Hahn WC, Hatton C, Kantoff PW, Kluk M, Kuo F, Jia Y, Joshi R, Longtine J, Manning A, Palescandolo E, Sharaf N, Sholl L, van Hummelen P, Wade J, Wollinson BM, Zepf D, Rollins BJ, Lindeman NI.

J Mol Diagn. 2014 Nov;16(6):660-72. doi: 10.1016/j.jmoldx.2014.06.004. Epub 2014 Aug 23.

PMID:
25157968
[PubMed - in process]
6.

Identifying suicidal symptoms in prostate cancer survivors using brief self-report.

Zhou ES, Hu JC, Kantoff PW, Recklitis CJ.

J Cancer Surviv. 2014 Aug 19. [Epub ahead of print]

PMID:
25135206
[PubMed - as supplied by publisher]
7.

Role of Androgen Deprivation Therapy in Early Salvage Radiation Among Patients With Prostate-Specific Antigen Level of 0.5 or Less.

Parekh A, Chen MH, Graham P, Mahal BA, Hirsch AE, Nakabayashi M, Evan C, Kantoff PW, Martin NE, Nguyen PL.

Clin Genitourin Cancer. 2014 Jun 27. pii: S1558-7673(14)00127-X. doi: 10.1016/j.clgc.2014.06.016. [Epub ahead of print]

PMID:
25103271
[PubMed - as supplied by publisher]
8.

Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them.

Nguyen PL, Alibhai SM, Basaria S, D'Amico AV, Kantoff PW, Keating NL, Penson DF, Rosario DJ, Tombal B, Smith MR.

Eur Urol. 2014 Aug 2. pii: S0302-2838(14)00650-2. doi: 10.1016/j.eururo.2014.07.010. [Epub ahead of print] Review.

PMID:
25097095
[PubMed - as supplied by publisher]
9.

Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer.

McKay RR, Zukotynski KA, Werner L, Voznesensky O, Wu JS, Smith SE, Jiang Z, Melnick K, Yuan X, Kantoff PW, Montgomery B, Balk SP, Taplin ME.

Prostate Cancer Prostatic Dis. 2014 Dec;17(4):325-31. doi: 10.1038/pcan.2014.28. Epub 2014 Aug 5.

PMID:
25091040
[PubMed - in process]
10.

Development of multinuclear polymeric nanoparticles as robust protein nanocarriers.

Wu J, Kamaly N, Shi J, Zhao L, Xiao Z, Hollett G, John R, Ray S, Xu X, Zhang X, Kantoff PW, Farokhzad OC.

Angew Chem Int Ed Engl. 2014 Aug 18;53(34):8975-9. doi: 10.1002/anie.201404766. Epub 2014 Jul 2.

PMID:
24990548
[PubMed - in process]
11.

Suicidal ideation in prostate cancer survivors: understanding the role of physical and psychological health outcomes.

Recklitis CJ, Zhou ES, Zwemer EK, Hu JC, Kantoff PW.

Cancer. 2014 Nov 1;120(21):3393-400. doi: 10.1002/cncr.28880. Epub 2014 Jun 24.

PMID:
24962506
[PubMed - in process]
12.

Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T.

Small EJ, Higano CS, Kantoff PW, Whitmore JB, Frohlich MW, Petrylak DP.

Prostate Cancer Prostatic Dis. 2014 Sep;17(3):259-64. doi: 10.1038/pcan.2014.21. Epub 2014 Jun 24.

PMID:
24957547
[PubMed - in process]
Free PMC Article
13.

Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer.

Yoo S, Pettersson A, Jordahl KM, Lis RT, Lindstrom S, Meisner A, Nuttall EJ, Stack EC, Stampfer MJ, Kraft P, Brown M, Loda M, Giovannucci EL, Kantoff PW, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2027-31. doi: 10.1158/1055-9965.EPI-14-0020. Epub 2014 Jun 12.

PMID:
24925673
[PubMed - in process]
14.

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer.

Braunstein LZ, Chen MH, Loffredo M, Kantoff PW, D'Amico AV.

Prostate Cancer. 2014;2014:230812. doi: 10.1155/2014/230812. Epub 2014 Apr 22.

PMID:
24864213
[PubMed]
Free PMC Article
15.

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

Guancial EA, Werner L, Bellmunt J, Bamias A, Choueiri TK, Ross R, Schutz FA, Park RS, O'Brien RJ, Hirsch MS, Barletta JA, Berman DM, Lis R, Loda M, Stack EC, Garraway LA, Riester M, Michor F, Kantoff PW, Rosenberg JE.

Cancer Med. 2014 Aug;3(4):835-44. doi: 10.1002/cam4.262. Epub 2014 May 21.

PMID:
24846059
[PubMed - in process]
16.

Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates.

Choueiri TK, Jacobus S, Bellmunt J, Qu A, Appleman LJ, Tretter C, Bubley GJ, Stack EC, Signoretti S, Walsh M, Steele G, Hirsch M, Sweeney CJ, Taplin ME, Kibel AS, Krajewski KM, Kantoff PW, Ross RW, Rosenberg JE.

J Clin Oncol. 2014 Jun 20;32(18):1889-94. doi: 10.1200/JCO.2013.52.4785. Epub 2014 May 12.

PMID:
24821883
[PubMed - indexed for MEDLINE]
17.

Prostate cancer, version 2.2014.

Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D'Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kane CJ, Kawachi MH, Kuettel M, Kuzel TM, Lee RJ, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M 3rd, Rohren E, Rosenfeld S, Schaeffer E, Small EJ, Sonpavde G, Srinivas S, Stein C, Strope SA, Tward J, Shead DA, Ho M.

J Natl Compr Canc Netw. 2014 May;12(5):686-718.

PMID:
24812137
[PubMed - in process]
18.

Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.

Hsieh CL, Fei T, Chen Y, Li T, Gao Y, Wang X, Sun T, Sweeney CJ, Lee GS, Chen S, Balk SP, Liu XS, Brown M, Kantoff PW.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):7319-24. doi: 10.1073/pnas.1324151111. Epub 2014 Apr 28.

PMID:
24778216
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer.

Lohr JG, Adalsteinsson VA, Cibulskis K, Choudhury AD, Rosenberg M, Cruz-Gordillo P, Francis JM, Zhang CZ, Shalek AK, Satija R, Trombetta JJ, Lu D, Tallapragada N, Tahirova N, Kim S, Blumenstiel B, Sougnez C, Lowe A, Wong B, Auclair D, Van Allen EM, Nakabayashi M, Lis RT, Lee GS, Li T, Chabot MS, Ly A, Taplin ME, Clancy TE, Loda M, Regev A, Meyerson M, Hahn WC, Kantoff PW, Golub TR, Getz G, Boehm JS, Love JC.

Nat Biotechnol. 2014 May;32(5):479-84. doi: 10.1038/nbt.2892. Epub 2014 Apr 20.

PMID:
24752078
[PubMed - in process]
Free PMC Article
20.

Natural history of untreated prostate specific antigen radiorecurrent prostate cancer in men with favorable prognostic indicators.

Martin NE, Chen MH, Beard CJ, Nguyen PL, Loffredo MJ, Renshaw AA, Kantoff PW, D'Amico AV.

Prostate Cancer. 2014;2014:912943. doi: 10.1155/2014/912943. Epub 2014 Feb 20.

PMID:
24701353
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk